{"id":"https://openalex.org/W1998085563","doi":"https://doi.org/10.1016/j.jaad.2005.10.010","title":"Dermatologic side effects associated with the epidermal growth factor receptor inhibitors","display_name":"Dermatologic side effects associated with the epidermal growth factor receptor inhibitors","publication_year":2006,"publication_date":"2006-09-28","ids":{"openalex":"https://openalex.org/W1998085563","doi":"https://doi.org/10.1016/j.jaad.2005.10.010","mag":"1998085563","pmid":"https://pubmed.ncbi.nlm.nih.gov/17010747"},"language":"en","primary_location":{"id":"doi:10.1016/j.jaad.2005.10.010","doi":"https://doi.org/10.1016/j.jaad.2005.10.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jaad.2005.10.010","pdf_url":null,"source":{"id":"https://openalex.org/S58727509","display_name":"Journal of the American Academy of Dermatology","issn_l":"0190-9622","issn":["0190-9622","1097-6787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000606519","display_name":"Anna Liza C. Agero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Liza C. Agero","raw_affiliation_strings":["Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","From the Dermatology Service, Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"From the Dermatology Service, Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086674149","display_name":"Stephen W. Dusza","orcid":"https://orcid.org/0000-0002-0747-2479","observed_orcids":["https://orcid.org/0000-0002-0747-2479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen W. Dusza","raw_affiliation_strings":["From the Dermatology Service, Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Dermatology Service, Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016162938","display_name":"Cristiane Benvenuto-Andrade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristiane Benvenuto-Andrade","raw_affiliation_strings":["From the Dermatology Service, Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Dermatology Service, Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027415725","display_name":"Klaus Johannes BUSAM","orcid":"https://orcid.org/0000-0003-0888-9601","observed_orcids":["https://orcid.org/0000-0003-0888-9601"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klaus J. Busam","raw_affiliation_strings":["Dept of Pathology, Memorial Sloan Kettering Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology, Memorial Sloan Kettering Cancer Center","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083629751","display_name":"Patricia L. Myskowski","orcid":"https://orcid.org/0000-0001-6903-3335","observed_orcids":["https://orcid.org/0000-0001-6903-3335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Myskowski","raw_affiliation_strings":["From the Dermatology Service, Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Dermatology Service, Department of Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004712523","display_name":"Allan C. Halpern","orcid":"https://orcid.org/0000-0001-7320-1901","observed_orcids":["https://orcid.org/0000-0001-7320-1901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allan C. Halpern","raw_affiliation_strings":["From the Dermatology Service, Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Dermatology Service, Department of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":5.4427,"has_fulltext":false,"cited_by_count":380,"citation_normalized_percentile":{"value":0.98098859,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"55","issue":"4","first_page":"657","last_page":"670"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/dermatologic-adverse-effects","display_name":"dermatologic adverse effects","score":0.7540000081062317},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8809999823570251},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":1.0},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.5839999914169312},{"id":"https://openalex.org/keywords/pustular-rash","display_name":"pustular rash","score":0.6840000152587891},{"id":"https://openalex.org/keywords/egfr-signaling","display_name":"EGFR signaling","score":0.5910000205039978},{"id":"https://openalex.org/keywords/dry-skin","display_name":"dry skin","score":0.8579999804496765},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9369999766349792},{"id":"https://openalex.org/keywords/paronychia","display_name":"paronychia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8230000138282776},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9050536751747131},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8813393115997314},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8531705141067505},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8062070608139038},{"id":"https://openalex.org/C2778169587","wikidata":"https://www.wikidata.org/wiki/Q3896379","display_name":"Paronychia","level":2,"score":0.8015161752700806},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7426182627677917},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7179766893386841},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6343039870262146},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.614216148853302},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5837700366973877},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.5133673548698425},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4469262957572937},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4279041886329651},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3464350700378418},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3438318967819214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32365959882736206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3234894573688507}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004815","descriptor_name":"Epidermal Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jaad.2005.10.010","doi":"https://doi.org/10.1016/j.jaad.2005.10.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jaad.2005.10.010","pdf_url":null,"source":{"id":"https://openalex.org/S58727509","display_name":"Journal of the American Academy of Dermatology","issn_l":"0190-9622","issn":["0190-9622","1097-6787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"journal-article"},{"id":"pmid:17010747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17010747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W39773280","https://openalex.org/W73046920","https://openalex.org/W117475386","https://openalex.org/W1924476721","https://openalex.org/W1967763477","https://openalex.org/W1972119499","https://openalex.org/W1976887517","https://openalex.org/W1996941660","https://openalex.org/W1997655841","https://openalex.org/W2000221369","https://openalex.org/W2026440696","https://openalex.org/W2046882295","https://openalex.org/W2047138772","https://openalex.org/W2049399926","https://openalex.org/W2049484790","https://openalex.org/W2058992264","https://openalex.org/W2090359261","https://openalex.org/W2096287391","https://openalex.org/W2097584581","https://openalex.org/W2103134643","https://openalex.org/W2103384680","https://openalex.org/W2110835998","https://openalex.org/W2114291028","https://openalex.org/W2115131874","https://openalex.org/W2118011560","https://openalex.org/W2121306031","https://openalex.org/W2123265037","https://openalex.org/W2126314379","https://openalex.org/W2127101185","https://openalex.org/W2135836172","https://openalex.org/W2141937666","https://openalex.org/W2142564546","https://openalex.org/W2142661339","https://openalex.org/W2151979638","https://openalex.org/W2157036179","https://openalex.org/W2167368130","https://openalex.org/W2168377135","https://openalex.org/W2170083676","https://openalex.org/W2171406894","https://openalex.org/W2243263305","https://openalex.org/W2246276357","https://openalex.org/W2248744504","https://openalex.org/W2255070730","https://openalex.org/W2272276923","https://openalex.org/W2405151655","https://openalex.org/W2408748883","https://openalex.org/W2587309930","https://openalex.org/W2602320913","https://openalex.org/W2604130272","https://openalex.org/W4285719527","https://openalex.org/W6692141109","https://openalex.org/W6713577214","https://openalex.org/W6736054113"],"related_works":["https://openalex.org/W7096340763","https://openalex.org/W2163592822","https://openalex.org/W2381661869","https://openalex.org/W4253369150","https://openalex.org/W2322011274","https://openalex.org/W4230679792","https://openalex.org/W2397172649","https://openalex.org/W2064198754","https://openalex.org/W73132195","https://openalex.org/W2767910165"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":24},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":22},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":26},{"year":2012,"cited_by_count":29}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}